top of page

​

 

At MediNect Ophtho, we are committed to delivering high quality preclinical services through a collaborative, communicative, and client-focused approach. Our process is designed to be transparent, efficient, and responsive, ensuring results that are timely, accurate, and actionable.

​

Initial Discussion 

We begin with an informal conversation to understand your research goals and challenges. This helps us assess feasibility, identify the most appropriate study design, and align on timelines from the outset.

​

Consultation & Study Planning 

With a clear scope in hand, our preclinical experts work closely with you to develop a tailored study plan. This collaborative planning phase is key to ensuring study success and has been repeatedly highlighted by clients as a major value-add. See our testimonials for more.​

 

In-life Study Phase

Once study and welfare approvals are in place, we execute the study according to plan—carrying out model induction, dosing, sample collection, imaging, and more. We keep you closely informed throughout, enabling quick, informed decisions on sampling, protocol adjustments, or future studies.

​

Study Completion & Reporting

Following completion, we analyse your data and deliver results with a fast turnaround—empowering you to make timely decisions on next steps. We can provide a comprehensive final report including results, expert interpretation, and recommendations for further research or development.

Collaborating

At MediNect Ophtho, we are committed to providing high-quality preclinical services that meet the needs of our clients.
Our collaborative approach ensures that we deliver results that are timely, accurate, and actionable.

HOW WE WORK

BOOK IN A FREE CONSULTATION

Thanks for submitting!

MediNect Bioservices Ltd is a registered company in Northern Ireland, UK

​

Company Number: NI686323

​

C/O QUBIS LTD
63 UNIVERSITY ROAD
BELFAST
NORTHERN IRELAND
BT7 1NF

​

©2025 by MediNect Bioservices. Proudly created with Wix.com

bottom of page